{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:02:52Z","timestamp":1784682172039,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008307","name":"Beckman Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacc.2026.02.5118","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:51:35Z","timestamp":1775659895000},"page":"2922-2924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Not All Hematologic Malignancies Are Created Equal"],"prefix":"10.1016","volume":"87","author":[{"given":"Stephanie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Wha","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacc.2026.02.5118_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaccao.2025.07.001","article-title":"Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC CardioOncology state of the art review","volume":"7","author":"Alhuneafat","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"9","key":"10.1016\/j.jacc.2026.02.5118_bib2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1055-9965.EPI-23-1635","article-title":"Long-term risks of cardiovascular death among older patients with major hematological malignancies: a population-based cohort study from SEER database","volume":"33","author":"Zhang","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jacc.2026.02.5118_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular disease among adults with cancer: a population-based cohort study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jacc.2026.02.5118_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2026.02.5089","article-title":"Cardiovascular disease risk in adults with hematological malignancies: a population-based cohort study using linked databases","author":"Geels","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2026.02.5118_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2026.02.5118_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jacc.2026.02.5118_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamaoncol.2025.5785","article-title":"Clonal hematopoiesis and cardiovascular disease risk after cancer therapy in patients with solid tumors","volume":"12","author":"Shyr","year":"2026","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.jacc.2026.02.5118_bib8","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.1161\/CIR.0000000000001404","article-title":"Clonal hematopoiesis and its cardiovascular implications: a scientific statement from the American Heart Association","volume":"153","author":"Rhee","year":"2026","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacc.2026.02.5118_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaccao.2023.05.004","article-title":"Cardioprotection in patients at high risk of anthracycline-induced cardiotoxicity: JACC CardioOncology primer","volume":"5","author":"Henriksen","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"12","key":"10.1016\/j.jacc.2026.02.5118_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.46201","article-title":"Biomarker-guided cardioprotection for patients treated with anthracyclines: a randomized clinical trial","volume":"8","author":"Xia","year":"2025","journal-title":"JAMA Netw Open"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726056548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726056548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:27:13Z","timestamp":1784680033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726056548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0735109726056548"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.02.5118","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Not All Hematologic Malignancies Are Created Equal","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.02.5118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.02.5089","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 the American College of Cardiology Foundation. Published by Elsevier. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}